world’s first Intranasal vaccine
-
Bharat Biotech’s Nasal Vaccine ‘iNCOVACC’ To Be Available at Rs 325 for Govt Hospitals
Bharat Biotech's "iNCOVACC" is the world's first Intranasal vaccine for COVID to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. Bharat Biotech International (BBIL) announced that iNCOVACC (BBV154), is scheduled to be introduced in the...
Published On December 29th, 2022